NIKKEI 225
27,348.78 +21.67 (+0.08%) HANG SENG
21,902.35 +60.02 (+0.27%) CRUDE OIL
79.27 +0.40 (+0.51%) GOLD FUTURES
1,942.90 -2.40 (-0.12%) DOW
34,086.04 +368.95 (+1.09%) BTC-GBP
18,780.18 +158.95 (+0.85%)
BEAM Feb 2023 50.000 call
| Previous close | 23.28 |
| Open | N/A |
| Bid | 24.30 |
| Ask | 27.00 |
| Strike | 50.00 |
| Expiry date | 2023-02-17 |
| Day's range | 23.28 - 25.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
- Simply Wall St.
Shareholders in Beam Therapeutics (NASDAQ:BEAM) are in the red if they invested a year ago
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders should be happy to see the share price up 16% in the last month...
- Motley Fool
5 Top Stocks for February
The Nasdaq Composite has surged over 11% so far this month as growth stocks retake center stage. Shopify (NYSE: SHOP), the Vanguard Growth ETF (NYSEMKT: VUG), Nio (NYSE: NIO), Beam Therapeutics (NASDAQ: BEAM), and Roku (NASDAQ: ROKU) have that kind of potential. Here's what makes each company a great buy now, according to five Motley Fool contributors.
- Motley Fool
3 Great Growth Stocks Down 20% or More to Buy Now
Three Motley Fool contributors were asked to identify great growth stocks down 20% or more to buy now. Here's why they chose Beam Therapeutics (NASDAQ: BEAM), Maravai LifeSciences (NASDAQ: MRVI), and Novavax (NASDAQ: NVAX). Keith Speights (Beam Therapeutics): Beam Therapeutics was flying high in the early part of 2021.
